| Fiscal Period | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Period End Date | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
| Issuance( Retirement)of Debt Net | 1.02 | - | 0.00 | 0.00 |
| Net Changein Cash | 0.28 | 0.00 | -0.01 | 0.00 |
| Cash Taxes Paid | 0.00 | - | - | - |
| Net Income/ Starting Line | -0.68 | -0.66 | -6.01 | -10.40 |
| Changesin Working Capital | 1.72 | 0.61 | 1.05 | 0.52 |
| Cashfrom Operating Activities | 1.20 | 0.00 | 0.00 | 0.10 |
| Cash Interest Paid | 0.24 | - | - | - |
| Cashfrom Financing Activities | 0.78 | 0.00 | 0.00 | 0.00 |
| Depreciation/ Depletion | 0.09 | 0.09 | 4.95 | 9.92 |
| Other Investing Cash Flow Items Total | -1.70 | 0.00 | 0.00 | -0.10 |
| Capital Expenditures | 0.00 | 0.00 | -0.01 | 0.00 |
| period Type | - | - | - | - |
| Non- Cash Items | 0.06 | -0.05 | 0.01 | 0.05 |
| Financing Cash Flow Items | -0.24 | 0.00 | - | - |
| period Length | 12.00 | 12.00 | 12.00 | 12.00 |
| Cashfrom Investing Activities | -1.70 | 0.00 | -0.01 | -0.10 |
Transgene Biotek Dividend Transgene Biotek Bonus Transgene Biotek News Transgene Biotek AGM Transgene Biotek Rights Transgene Biotek Splits Transgene Biotek Board Meetings Transgene Biotek Key Metrics Transgene Biotek Shareholdings Transgene Biotek Profit Loss Transgene Biotek Balance Sheet Transgene Biotek Q1 Results Transgene Biotek Q2 Results Transgene Biotek Q3 Results Transgene Biotek Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks